Biomerica, Inc.

BMRA Healthcare Medical Devices

Biomerica, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $4.5 million, down 16.2% from fiscal 2025.

Revenue
−8.33%
EPS
−46,350.0%
Free cash flow
−199.3%

Quarter to August 2026, against a year earlier

1.61 0.00 0.00%
Market cap
$7.4M
P/E
0.0×
Fwd P/E
11.4×
Dividend yield
—
F-score
4/9
Altman Z
−12.45
Beneish M
−2.06
Dividend safety
n/a
Aug '26 May '26 Feb '26 Nov '25 Older periods
ROE
(113.80%) (112.10%) (94.32%) (84.30%)

+8 more TTM periods

Piotroski F-Score
2 4 3 4
ROA
(67.12%) (59.43%) (68.12%) (60.49%)
ROIC
(370.83%) (251.51%) (168.95%) (173.99%)
Return on Tangible Assets
(189.73%) (234.04%) (157.33%) (108.87%)
Average Days of Receivables
75.47 64.34 79.40 77.54
Free Cash Flow per Share
(1.20) (1.18) (1.07) (1.02)
Free Cash Flow
(3.95) (3.43) (3.23) (2.97)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026